Capricor Therapeutics CAPR
NASDAQ CAPR
$8.95 +0.01 (+0.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Selling, General & Administrative (2010 - 2026)

Updated

Capricor Therapeutics' Selling, General & Administrative was $14.08 million in Q2 2026, up 148.3% from $5.67 million a year earlier and up 49.8% from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Capricor Therapeutics' Selling, General & Administrative was $35.42 million through Jun 30, 2026, up 81.9% year-over-year; for FY2025, it was $23.69 million, up 59.3% from FY2024.

  • Selling, General & Administrative has now increased for six consecutive years, with a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $14.87 million in FY2024 (+16.1%), $12.81 million in FY2023 (+22.8%), $10.43 million in FY2022 (+37.0%) and $7.61 million in FY2021 (+37.3%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
  • Compared with a year earlier, Selling, General & Administrative has increased for 26 straight quarters, with growth averaging 61.1% over the last eight quarters.
  • Across the past five years, year-over-year growth in Selling, General & Administrative ran from 7.4% in Q2 2024 to 148.3% in Q2 2026.
  • Per Business Quant data, CAPR's Selling, General & Administrative in the three quarters before Q2 2026 was $9.4 million (Q1 2026), $6.02 million (Q4 2025) and $5.92 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Capricor Therapeutics 519.49 Mn 519.49 Mn - 14.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.08 Mn
Mar 31, 2026 9.40 Mn
Dec 31, 2025 6.02 Mn
Sep 30, 2025 5.92 Mn
Jun 30, 2025 5.67 Mn
Mar 31, 2025 6.07 Mn
Dec 31, 2024 4.27 Mn
Sep 30, 2024 3.46 Mn
Jun 30, 2024 3.06 Mn
Mar 31, 2024 4.07 Mn
Dec 31, 2023 3.43 Mn
Sep 30, 2023 3.02 Mn
Jun 30, 2023 2.85 Mn
Mar 31, 2023 3.51 Mn
Dec 31, 2022 2.79 Mn
Sep 30, 2022 2.56 Mn
Jun 30, 2022 2.36 Mn
Mar 31, 2022 2.72 Mn
Dec 31, 2021 2.12 Mn
Sep 30, 2021 1.80 Mn
API Access

Capricor Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CAPR&period=max&api_key=YOUR_API_KEY